For The Public (SE) For The Public (IT) For The Public (DE) For The Public (FI) For The Public (CZ) For The Public (GR)
Home
About Us
Contact us
Consortium Description
Management
Research Partners
Partner Institutions
Research Activities
Summary
Dissemination of Knowledge
News
Contact
Press Releases
Events
FP6 Facts
For The Public
(Multilingual Content)
Project
News And Views
FP6

Content : Consortium Description
Posted on Monday, May 07 @ 17:20:57 EEST by admin
About Us
 
The Apotherapy consortium possesses a blend of academic specialists and SME with complementary expertise on molecular and cellular biology, molecular medicine, cancer immunotherapy and biomaterial technology. The tasks assigned to the participants aim at maximizing the use of individual expertise and resources for the benefit of the joined research. For more information about the consortium partners, please click follow this link.


CD40, cancer, therapy, PI3 kinase, immunotherapy, gene therapy, signaling, European Commission Program, FP6, Virtual Medical Lab, Faculty of Medicine, University of Crete
 
 



Visitors:
Designed by: George Savakis for Virtual Medical Lab (Faculty of Medicine - Univercity of Crete)